Sio Capital Management’s Terns Pharmaceuticals TERN Stock Holding History
Bought
Maintained
Sold
Other funds holding TERN
Sio Capital Management's TERN Position: Q2 2026 in Review
Sio Capital Management sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 10,100 shares — an estimated $532K sold.
Sio Capital Management first reported a position in TERN in Q3 2024 and held it in 7 quarters. The position peaked at $532K in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.
- Sio Capital Management reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
- Sio Capital Management sold 10,100 Terns Pharmaceuticals shares in Q2 2026, an estimated $532K.
- Sio Capital Management first reported a position in Terns Pharmaceuticals in Q3 2024 and held it in 7 quarters.
- Sio Capital Management's Terns Pharmaceuticals position peaked at $532K in Q1 2026.
- 1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.
Based on Sio Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.